China National Medicines Corporation Ltd. Class ASSE: 600511

Announcement on Change of Sponsor Representative for Continuous Supervision of the Shareholding Restructuring Reform

· Issued by China National Medicines Corporation Ltd. Class A via Shanghai Stock Exchange
Announcement on Change of Sponsor Representative for Continuous Supervision of the Shareholding Restructuring Reform

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment